Home > Insider Trading > Filing (0001171843-15-002085)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365174	M Mark Silverberg	1925 West Field Court Suite 300 Lake Forest IL 60045	Exec Vp, Ops Global Qa&Techsrv	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-04-21	60,000	$2.61	285,522	No	4	M	Direct
Common Stock	Disposition	2015-04-21	29,000	$55.00	256,522	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2015-04-21	60,000	$0.00	60,000	$2.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2015-05-21	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2015. Upon execution of the transaction disclosed on this Form 4, all securities subject to the 10b5-1 trading plan have been transacted and the plan has expired pursuant to its terms.
Proceeds from the sale were used to pay exercise price and taxes due upon exercise of options.
Amount of Shares Beneficially Owned Following Reported Transaction includes 22,535 unvested shares subject to restricted stock awards and 233,987 shares owned outright.
The option vested in three annual installments with 20,000 options vesting on May 21, 2011, May 21, 2012 and May 21, 2013.
There was no consideration given in exchange for the security.